CSIRO Innovation | Main Sequence VF

Venture Capital Est. 2017

Also known as CSIRO.

Website →
AUD 232M
Estimated FUM
Type
Venture Capital
HQ
Sydney, NSW, Australia
Founded
2017
Focus
Deeptech

About

The CSIRO Innovation Fund (managed by and trading as Main Sequence Ventures) is a deeptech fund, investing in companies translating research into global-scale businesses. Main Sequence Ventures knows that this takes more than money. We have our genesis in CSIRO and have access to a deep well of data scientists, physicists, synthetic biologists, chemists, astronomers and experts in other disciples. Each member of the management team has been an entrepreneur and understands the difficulties of building a company. We are here to help. We work harder to understand the world that these founders imagine. We are as comfortable in the lab as we are on the front-line with customers. We will invest capital, and ourselves, to systematically reduce risk and increase opportunity by combining the operational velocity of startups with the deep curiosity of Australia's research sector.

Investment Focus

Investment size
AUD 50K - AUD 7M

Reported investment size. Actual commitments may vary by stage, ownership and follow-on participation.

Focus Areas
Stages
Seed Series A Series B
Domains
Technology
Focus
Deeptech Specialist
Investment Geographies
Primary Markets
Australia
Coverage
Country-focused
Regions
Oceania

Coverage is a guide only.

Location

Headquarters
Sydney, NSW, Australia
Office Presence
1 country
Australia
1 known office
Sydney, NSW, Australia (HQ)

People also viewed